Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Muscle Invasive Bladder Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02343614
What this trial is testing

Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer

Who this might be right for
Non Muscle Invasive Bladder Cancer
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 58
Not applicableStudy completedNCT01750970
What this trial is testing

Endoscopic Resection of Bladder Tumors

Who this might be right for
Bladder Tumor
Hopital Foch 68
Early research (Phase 1)Not Yet RecruitingNCT07725796
What this trial is testing

Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNMIBCUrothelial Carcinoma Bladder+5 more
UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. 30
Post-approval studies (Phase 4)Study completedNCT02214602
What this trial is testing

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Carcinoma of Urinary Bladder, Superficial
Mansoura University 240
Testing effectiveness (Phase 2)Looking for participantsNCT05951179
What this trial is testing

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Protara Therapeutics 131
Testing effectiveness (Phase 2)Looking for participantsNCT07475403
What this trial is testing

Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerLiquid BiopsyImmunotherapy
Tianjin Medical University Second Hospital 53
Testing effectiveness (Phase 2)WithdrawnNCT05120622
What this trial is testing

Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerHigh-Risk CancerTremelimumab+2 more
University of British Columbia
Not applicableLooking for participantsNCT07036731
What this trial is testing

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Early research (Phase 1)Looking for participantsNCT06351904
What this trial is testing

RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Ractigen Therapeutics. 72
Not applicableActive Not RecruitingNCT07511517
What this trial is testing

BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder NeoplasmsUrinary Bladder NeoplasmsCarcinoma, Transitional Cell, Bladder
Oslo University Hospital 500
Not applicableUnknownNCT05146635
What this trial is testing

Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

Who this might be right for
Bladder Cancer
Mansoura University 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808216
What this trial is testing

Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT

Who this might be right for
Non Muscle Invasive Bladder Cancer
Tianjin First Central Hospital 54
Early research (Phase 1)Study completedNCT01458847
What this trial is testing

Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
BioCis Pharma Ltd 12
Testing effectiveness (Phase 2)Study completedNCT00192049
What this trial is testing

Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Eli Lilly and Company 90
Not applicableLooking for participantsNCT07225127
What this trial is testing

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

Who this might be right for
Bladder CancerRecurrent Bladder CancerNon-muscle Invasive Bladder Cancer (NMIBC)
University of Washington 408
Not applicableStudy completedNCT03091764
What this trial is testing

Evaluation of a Patient-Reported Symptom Index for NMIBC

Who this might be right for
Superficial Bladder Cancer
University of Sydney 498
Testing effectiveness (Phase 2)Active Not RecruitingNCT06187506
What this trial is testing

Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerHER-2 Protein Overexpression
Fudan University 20
Large-scale testing (Phase 3)Looking for participantsNCT07480356
What this trial is testing

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNon-Muscle Invasive Bladder CarcinomaNon-muscle Invasive Bladder Cancer With Carcinoma in Situ
Protara Therapeutics 284
Not applicableStudy completedNCT06768346
What this trial is testing

Hyperthermic Intra-Vesical Chemotherapy

Who this might be right for
Bladder Cancer
Queen Mary University of London 259
Large-scale testing (Phase 3)Active Not RecruitingNCT05714202
What this trial is testing

TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)

Who this might be right for
Bladder Cancer
Janssen Research & Development, LLC 1,135
Next Page